CXCL1 and hypertensive retinopathy: This study provides new evidence that the CXCL1-CXCR2 axis plays a critical role in the pathogenesis of hypertensive retinopathy, and selective blockade of CXCL1-CXCR2 activation may be a potential treatment for HR.